Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines
1998

Cisplatin Sensitivity in Head and Neck Cancer Cell Lines

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): MJP Welters, AMJ Fichtinger-Schepman, RA Baan, MJ Flens, RJ Scheper, BJM Braakhuis

Primary Institution: TNO Nutrition and Food Research Institute; Vrije Universiteit

Hypothesis

What factors influence cisplatin sensitivity in head and neck squamous cell carcinoma (HNSCC) cell lines?

Conclusion

The study found an inverse correlation between the expression of multidrug resistance-associated protein (MRP) and cisplatin sensitivity in HNSCC cell lines.

Supporting Evidence

  • An inverse correlation was found between MRP levels and IC50 values.
  • GSH levels did not correlate with cisplatin sensitivity.
  • High expression of MRP was associated with increased platinum accumulation in cells.

Takeaway

This study looked at how certain proteins affect how well cancer cells respond to a drug called cisplatin, finding that more of a specific protein (MRP) might actually help the cells take in more of the drug.

Methodology

The study analyzed eight HNSCC cell lines for their sensitivity to cisplatin, measuring IC50 values, GSH levels, and expression of GST and MDR proteins through immunocytochemistry.

Limitations

The study did not explore all potential factors influencing cisplatin sensitivity, and the results may not be generalizable to all HNSCC cases.

Participant Demographics

The study involved human head and neck squamous cell carcinoma cell lines.

Statistical Information

P-Value

0.04

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication